Document:

Amended & Restated 1998 Director Incentive Plan

 

Exhibit 10.1

ASPECT MEDICAL SYSTEMS, INC.

AMENDED AND RESTATED 1998 DIRECTOR

EQUITY INCENTIVE PLAN

 

		
	1.	
    Purpose.

     
The purpose of this Amended and Restated
1998 Director Equity Incentive Plan (the “Plan”)
of Aspect Medical Systems, Inc. (the “Company”) is to
advance the interests of the Company’s stockholders by
enhancing the Company’s ability to attract, retain and
motivate outside directors of the Company by providing such
directors with equity ownership opportunities and thereby better
aligning the interests of such directors with those of the
Company’s stockholders.

 

		
	2.	
    Administration.

     
The Plan will be administered by the
Company’s Board of Directors (the “Board”). The
Board shall have authority to grant Awards (as defined in
Section 3) and to adopt, amend and repeal such
administrative rules, guidelines and practices relating to the
Plan as it shall deem advisable. The Board may correct any
defect, supply any omission or reconcile any inconsistency in
the Plan or any Award in the manner and to the extent it shall
deem expedient to carry the Plan into effect and it shall be the
sole and final judge of such expediency. All decisions by the
Board shall be made in the Board’s sole discretion and
shall be final and binding on all persons having or claiming any
interest in the Plan or in any Award. No director or person
acting pursuant to the authority delegated by the Board shall be
liable for any action or determination relating to or under the
Plan made in good faith.

 

		
	3.	
    Participation in the Plan.

     
Directors of the Company who are not full-time
employees of the Company or any subsidiary of the Company
(“outside directors”) shall be eligible to receive
options, restricted stock awards and other stock unit awards
(each an “Award”) under the Plan. Each person who
receives an Award under the Plan is deemed a
“Participant”.

 

		
	4.	
    Stock Subject to the Plan.

     
(a) The maximum number of shares of the
Company’s Common Stock, par value $.01 per share
(“Common Stock”), which may be issued under the Plan
shall be 350,000 shares, subject to adjustment as provided
in Section 9. If any Award expires or is terminated,
surrendered or canceled without having been fully exercised or
is forfeited in whole or in part (including as the result of
shares of Common Stock subject to such Award being repurchased
by the Company at the original issuance price pursuant to a
contractual repurchase right) or results in any Common Stock not
being issued, the unused Common Stock covered by such Award
shall again be available for the grant of Awards under the Plan.
Shares issued under the Plan may consist in whole or in part of
authorized but unissued shares or treasury shares.

     
(b) All options (as defined in
Section 5) granted under the Plan shall be non-statutory
options not entitled to special tax treatment under
Section 422 of the Internal Revenue Code of 1986, as
amended (the “Code”).

 

		
	5.	
    Terms, Conditions and Form of
    Options.

     
The Board may grant Options to purchase Common
Stock (each, an “Option”) and determine the number of
shares of Common Stock to be covered by each Option and the
conditions and limitations applicable to the exercise of each
Option, including conditions relating to applicable federal or
state securities laws, as it considers necessary or advisable.
Each Option granted under the Plan shall be evidenced by a

 

 

written agreement in such form as the Board shall
from time to time approve, which agreements may contain terms
and conditions in addition to but not inconsistent with those
set forth in the Plan.

     
(a) Option Exercise Price. The Option
exercise price per share of Common Stock for each Option granted
under the Plan shall equal (i) the last reported sales
price per share of Common Stock on the Nasdaq National Market
(or, if the Company is traded on a nationally recognized
securities exchange on the date of grant, the reported closing
sales price per share of Common Stock by such exchange) on the
date of grant (or if no such price is reported on such date such
price as reported on the nearest preceding day) or (ii) if
the Common Stock is not traded on the Nasdaq National Market or
such an exchange, the fair market value per share of Common
Stock on the date of grant as determined by the Board (the
“Fair Market Value”).

     
(b) Board Action. The Board may at
any time provide that any Options granted under the Plan become
immediately exercisable in full or in part.

     
(c) Termination. Each Option shall
terminate, and may no longer be exercised, on the earlier of the
date (i) 10 years after the date such Option was
granted or (ii) 60 days after the Participant ceases
to serve as a director of the Company; provided that, in the
event a Participant ceases to serve as a director due to his or
her death or disability (within the meaning of
Section 22(e)(3) of the Code or any successor provision),
then the exercisable portion of the Option may be exercised
within the period of 180 days following the date the
Participant ceases to serve as a director (but in no event later
than 10 years after the date such Option was granted) by
the Participant or by the person to whom the Option is
transferred by will, by the laws of descent and distribution, or
by written notice pursuant to Section 5(e).

     
(d) Exercise Procedure. An Option may
be exercised only by written notice to the Company at its
principal office accompanied by payment of the full
consideration for the shares as to which the Option is
exercised. Such payment may be made as follows:

		
	 	     
    (i) in cash or by check, payable to the
    order of the Company;
    
	 
	 	     
    (ii) by delivery of a promissory note of the
    Participant to the Company on terms determined by the Board;
    
	 
	 	     
    (iii) by payment of such other lawful
    consideration as the Board may determine; or
    
	 
	 	     
    (iv) any combination of the above permitted
    forms of payment.
    

     
(e) Exercise by Representative Following
Death of Director. A Participant, by written notice to the
Company, may designate one or more persons (and from time to
time change such designation), including his or her legal
representative, who, by reason of the Participant’s death,
shall acquire the right to exercise all or a portion of the
Option. If the person or persons so designated wish to exercise
any portion of the Option, they must do so within the term of
the Option as provided herein. Any exercise by a representative
shall be subject to the provisions of the Plan.

 

		
	6.	
    Restricted Stock.

     
(a) General. The Board may grant
Awards entitling eligible outside directors to acquire shares of
Common Stock (“Restricted Stock”), subject to the
right of the Company to repurchase all or part of such shares at
their issue price or other stated or formula price from the
Participant in the event that conditions specified by the Board
in the applicable Award are not satisfied prior to the end of
the applicable restriction period or periods established by the
Board for such Award.

     
(b) Terms and Conditions. The Board
shall determine the terms and conditions of a Restricted Stock
Award, including the conditions for repurchase (or forfeiture)
and the issue price.

     
(c) Stock Certificates. Any stock
certificates issued in respect of a Restricted Stock Award shall
be registered in the name of the Participant and, unless
otherwise determined by the Board, deposited by the Participant,
together with a stock power endorsed in blank, with the Company
(or its designee). At the expiration of the applicable
restriction periods, the Company (or such designee) shall
deliver the certificates no longer subject to such restrictions
to the Participant or if the Participant has died, to the
beneficiary

 

 

designated, in a manner determined by the Board,
by a Participant to receive amounts due or exercise rights of
the Participant in the event of the Participant’s death
(the “Designated Beneficiary”). In the absence of an
effective designation by a Participant, “Designated
Beneficiary” shall mean the Participant’s estate.

 

		
	7.	
    Other Stock-Based Awards.

     
Other Awards of shares of Common Stock, and other
Awards that are valued in whole or in part by reference to, or
are otherwise based on, shares of Common Stock or other
property, may be granted hereunder to Participants (“Other
Stock Unit Awards”), including without limitation Awards
entitling recipients to receive shares of Common Stock to be
delivered in the future. Such Other Stock Unit Awards shall also
be available as a form of payment in the settlement of other
Awards granted under the Plan or as payment in lieu of
compensation to which a Participant is otherwise entitled. Other
Stock Unit Awards may be paid in shares of Common Stock or cash,
as the Board shall determine. Subject to the provisions of the
Plan, the Board shall determine the conditions of each Other
Stock Unit Awards, including any purchase price applicable
thereto.

 

		
	8.	
    Limitation of Rights.

     
(a) No Right to Continue as a
Director. Neither the Plan, nor the granting of an Award nor
any other action taken pursuant to the Plan, shall constitute or
be evidence of any agreement or understanding, express or
implied, that the Company will retain the Participant as a
director for any period of time.

     
(b) No Stockholder Rights for Awards.
No Participant nor a Designated Beneficiary thereof shall have
any rights as a stockholder with respect to any shares of Common
Stock to be distributed with respect to an Award until becoming
the record holder of such shares.

 

		
	9.	
    Adjustment to Common Stock.

     
(a) In the event of any stock split, reverse
stock split, stock dividend, recapitalization, combination of
shares, reclassification of shares, spin-off or other similar
change in capitalization or event, or any distribution to
holders of Common Stock other than an ordinary cash dividend,
(i) the number and class of securities available under this
Plan, (ii) the number and class of securities and exercise
price per share of each outstanding Option, (iii) the
repurchase price per share subject to each outstanding
Restricted Stock Award and (vi) the share- and
per-share-related provisions of each outstanding Other Stock
Unit Award, shall be appropriately adjusted by the Company (or
substituted Awards may be made, if applicable) to the extent
determined by the Board.

     
(b) In the event of a proposed liquidation
or dissolution of the Company, the Board shall upon written
notice to the Participants provide that all then unexercised
Options will (i) become exercisable in full as of a
specified time at least 10 business days prior to the effective
date of such liquidation or dissolution and (ii) terminate
effective upon such liquidation or dissolution, except to the
extent exercised before such effective date. The Board may
specify the effect of a liquidation or dissolution on any
Restricted Stock Award or Other Stock Unit Awards granted under
the Plan at the time of grant.

 

		
	10.	
    Modification, Extension and Renewal of
    Awards.

     
The Board shall have the power to modify or amend
outstanding Awards; provided, however, that no modification or
amendment may (i) have the effect of altering or impairing
any rights or obligations of any Award previously granted
without the consent of the Participant, or (ii) modify the
number of shares of Common Stock subject to the Award (except as
provided in Section 9).

 

 

 

		
	11.	
    Acquisition and Change in Control
    Events

     
(a) Definitions

		
	 	     
    (i) A “Acquisition Event” shall
    mean:
    

		
	 	     
    (A) any merger or consolidation of the
    Company with or into another entity as a result of which all of
    the Common Stock is converted into or exchanged for the right to
    receive cash, securities or other property or is
    cancelled; or
    
	 
	 	     
    (B) any exchange of all of the Common Stock
    of the Company for cash, securities or other property pursuant
    to a share exchange transaction.
    

		
	 	     
    (ii) A “Change in Control Event”
    shall mean:
    

		
	 	     
    (A) the acquisition by an individual, entity
    or group (within the meaning of Section 13(d)(3) or
    14(d)(2) of the Securities Exchange Act of 1934, as amended (the
    “Exchange Act”)) (a “Person”) of beneficial
    ownership of any capital stock of the Company if, after such
    acquisition, such Person beneficially owns (within the meaning
    of Rule 13d-3 promulgated under the Exchange Act) 30% or
    more of either (x) the then-outstanding shares of common
    stock of the Company (the “Outstanding Company Common
    Stock”) or (y) the combined voting power of the
    then-outstanding securities of the Company entitled to vote
    generally in the election of directors (the “Outstanding
    Company Voting Securities”); provided, however, that
    for purposes of this subsection (A), the following
    acquisitions shall not constitute a Change in Control Event:
    (x) any acquisition directly from the Company (excluding an
    acquisition pursuant to the exercise, conversion or exchange of
    any security exercisable for, convertible into or exchangeable
    for common stock or voting securities of the Company, unless the
    Person exercising, converting or exchanging such security
    acquired such security directly from the Company or an
    underwriter or agent of the Company), (y) any acquisition
    by any employee benefit plan (or related trust) sponsored or
    maintained by the Company or any corporation controlled by the
    Company, or (z) any acquisition by any corporation pursuant
    to a Business Combination (as defined below) which complies with
    clauses (x) and (y) of
    subsection (C) of this definition; or
    
	 
	 	     
    (B) such time as the Continuing Directors
    (as defined below) do not constitute a majority of the Board
    (or, if applicable, the Board of Directors of a successor
    corporation to the Company), where the term “Continuing
    Director” means at any date a member of the Board
    (x) who was a member of the Board on March 25, 2005 or
    (y) who was nominated or elected subsequent to such date by
    at least a majority of the directors who were Continuing
    Directors at the time of such nomination or election or whose
    election to the Board was recommended or endorsed by at least a
    majority of the directors who were Continuing Directors at the
    time of such nomination or election; provided, however,
    that there shall be excluded from this clause (y) any
    individual whose initial assumption of office occurred as a
    result of an actual or threatened election contest with respect
    to the election or removal of directors or other actual or
    threatened solicitation of proxies or consents, by or on behalf
    of a person other than the Board; or
    
	 
	 	     
    (C) the consummation of a merger,
    consolidation, reorganization, recapitalization or share
    exchange involving the Company or a sale or other disposition of
    all or substantially all of the assets of the Company (a
    “Business Combination”), unless, immediately following
    such Business Combination, each of the following two conditions
    is satisfied: (x) all or substantially all of the
    individuals and entities who were the beneficial owners of the
    Outstanding Company Common Stock and Outstanding Company Voting
    Securities immediately prior to such Business Combination
    beneficially own, directly or indirectly, more than 50% of the
    then-outstanding shares of common stock and the combined voting
    power of the then-outstanding securities entitled to vote
    generally in the election of directors, respectively, of the
    resulting or acquiring corporation in such Business Combination
    (which shall include, without limitation, a corporation which as
    a result of such transaction owns the Company or substantially
    all of the Company’s assets either directly or through one
    or more subsidiaries) (such resulting or acquiring corporation
    is referred to herein as the
    

 

 

		
	 	
    “Acquiring Corporation”) in
    substantially the same proportions as their ownership of the
    Outstanding Company Common Stock and Outstanding Company Voting
    Securities, respectively, immediately prior to such Business
    Combination and (y) no Person (excluding any employee
    benefit plan (or related trust) maintained or sponsored by the
    Company or by the Acquiring Corporation) beneficially owns,
    directly or indirectly, 30% or more of the then-outstanding
    shares of common stock of the Acquiring Corporation, or of the
    combined voting power of the then-outstanding securities of such
    corporation entitled to vote generally in the election of
    directors (except to the extent that such ownership existed
    prior to the Business Combination).
    

     
(b) Effect on Options

		
	 	     
    (i) Acquisition Event. Upon the
    occurrence of a Acquisition Event (regardless of whether such
    event also constitutes a Change in Control Event), or the
    execution by the Company of any agreement with respect to an
    Acquisition Event (regardless of whether such event will result
    in a Change in Control Event), the Board shall provide that all
    outstanding Options shall be assumed, or equivalent options
    shall be substituted, by the acquiring or succeeding corporation
    (or an affiliate thereof); provided that if such
    Acquisition Event also constitutes a Change in Control Event,
    except to the extent specifically provided to the contrary in
    the instrument evidencing any Option or any other agreement
    between a Participant and the Company, such assumed or
    substituted Options shall become immediately exercisable in full
    upon the Acquisition Event. In the event of an Acquisition Event
    under the terms of which holders of Common Stock will receive
    upon consummation thereof a cash payment for each share of
    Common Stock surrendered pursuant to such Acquisition Event (the
    “Acquisition Price”), then the Board may instead
    provide that all outstanding Options shall terminate upon
    consummation of such Acquisition Event and that each Participant
    shall receive, in exchange therefor, a cash payment equal to the
    amount (if any) by which (A) the Acquisition Price
    multiplied by the number of shares of Common Stock subject to
    such outstanding Options (whether or not then exercisable),
    exceeds (B) the aggregate exercise price of such Options.
    
	 
	 	     
    For purposes hereof, an Option shall be
    considered to be assumed if, following consummation of the
    Acquisition Event, the Option confers the right to purchase, for
    each share of Common Stock subject to the Option immediately
    prior to the consummation of the Acquisition Event, the
    consideration (whether cash, securities or other property)
    received as a result of the Acquisition Event by holders of
    Common Stock for each share of Common Stock held immediately
    prior to the consummation of the Acquisition Event (and if
    holders were offered a choice of consideration, the type of
    consideration chosen by the holders of a majority of the
    outstanding shares of Common Stock); provided, however, that if
    the consideration received as a result of the Acquisition Event
    is not solely common stock of the acquiring or succeeding
    corporation (or an affiliate thereof), the Company may, with the
    consent of the acquiring or succeeding corporation, provide for
    the consideration to be received upon the exercise of Options to
    consist solely of common stock of the acquiring or succeeding
    corporation (or an affiliate thereof) equivalent in value (as
    determined by the Board) to the per share consideration received
    by holders of outstanding shares of Common Stock as a result of
    the Acquisition Event.
    
	 
	 	     
    Notwithstanding the foregoing, if the acquiring
    or succeeding corporation (or an affiliate thereof) does not
    agree to assume, or substitute for, such Options, then the Board
    shall, upon written notice to the Participants, provide that all
    then unexercised Options will become exercisable in full as of a
    specified time prior to the Acquisition Event and will terminate
    immediately prior to the consummation of such Acquisition Event,
    except to the extent exercised by the Participants before the
    consummation of such Acquisition Event.
    
	 
	 	     
    (ii) Change in Control Event that is not
    an Acquisition Event. Upon the occurrence of a Change in
    Control Event that does not also constitute an Acquisition
    Event, except to the extent specifically provided to the
    contrary in the instrument evidencing any Option or any other
    agreement between a Participant and the Company, all Options
    then-outstanding shall automatically become immediately
    exercisable in full.
    

 

 

     
(c) Effect on Restricted Stock Awards

		
	 	     
    (i) Acquisition Event that is not a
    Change in Control Event. Upon the occurrence of an
    Acquisition Event that is not a Change in Control Event, the
    repurchase and other rights of the Company under each
    outstanding Restricted Stock Award shall inure to the benefit of
    the Company’s successor and shall apply to the cash,
    securities or other property which the Common Stock was
    converted into or exchanged for pursuant to such Acquisition
    Event in the same manner and to the same extent as they applied
    to the Common Stock subject to such Restricted Stock Award.
    
	 
	 	     
    (ii) Change in Control Event. Upon
    the occurrence of a Change in Control Event (regardless of
    whether such event also constitutes an Acquisition Event),
    except to the extent specifically provided to the contrary in
    the instrument evidencing any Restricted Stock Award or any
    other agreement between a Participant and the Company, all
    restrictions and conditions on all Restricted Stock Awards
    then-outstanding shall automatically be deemed terminated or
    satisfied.
    

     
(d) Effect on Other Stock Unit
Awards. The Board may specify in an Award at the time of
grant the effect of an Acquisition Event and Change in Control
Event on any Other Stock Unit Award.

 

		
	12.	
    Amendment of the Plan.

     
The Board may amend, suspend or terminate the
Plan or any portion thereof at any time, provided that no
amendment shall be made without stockholder approval if such
approval is necessary to comply with any applicable tax or
regulatory requirements. Amendments requiring stockholder
approval shall become effective when adopted by the Board.

 

		
	13.	
    Withholding.

     
Each Participant shall pay to the Company, or
make provision satisfactory to the Company for payment of, any
taxes required by law to be withheld in connection with an Award
to such Participant. Except as the Board may otherwise provide
in an Award, for so long as the Common Stock is registered under
the Exchange Act, Participants may satisfy such tax obligations
in whole or in part by delivery of shares of Common Stock,
including shares retained from the Award creating the tax
obligation, valued at their Fair Market Value; provided,
however, except as otherwise provided by the Board, that the
total tax withholding where stock is being used to satisfy such
tax obligations cannot exceed the Company’s minimum
statutory withholding obligations (based on minimum statutory
withholding rates for federal and state tax purposes, including
payroll taxes, that are applicable to such supplemental taxable
income). Shares surrendered to satisfy tax withholding
requirements cannot be subject to any repurchase, forfeiture,
unfulfilled vesting or other similar requirements. The Company
may, to the extent permitted by law, deduct any such tax
obligations from any payment of any kind otherwise due to a
Participant.

 

		
	14.	
    Notice.

     
Any written notice to the Company required by any
of the provisions of the Plan shall be addressed to the
Treasurer of the Company and shall become effective when it is
received.

 

		
	15.	
    Governing Law.

     
The provisions of the Plan, all determinations
made and actions taken pursuant hereto and all Options
Restricted Stock Awards and Other Stock Unit Awards made
hereunder shall be governed by and interpreted in accordance
with the laws of the State of Delaware, without regard to any
applicable conflicts of law.

 

		
	16.	
    Compliance with Code Section 409A.

     
No Award shall provide for deferral of
compensation that does not comply with Section 409A of the
Code, unless the Board, at the time of grant, specifically
provides that the Award is not intended to comply with
Section 409A of the code.

 

 

 

		
	17.	
    Effective Date and Term of Plan.

     
The Plan shall become effective on the date of
approval by the stockholders of the Company. No Awards shall be
granted under the Plan after the completion of ten years from
the earlier of (i) the date on which the Plan was adopted
by the Board or (ii) the date the Plan was approved by the
Company’s stockholders, but Awards previously granted may
extend beyond that date.Form of Stock Option Agreement

 

Exhibit 10.2

Aspect Medical Systems, Inc.

Nonstatutory Stock Option Agreement

Granted Under 1998 Director Stock Option Plan

1. Grant of Option.

This agreement evidences the grant by Aspect Medical Systems, Inc., a Delaware corporation (the
“Company”), on [date of grant] to [director name], a director of the Company (the “Participant”), of
an option to purchase, in whole or in part, on the terms provided herein and in the Company’s
Amended and Restated 1998 Director Equity Incentive Option Plan (the “Plan”), a total of [insert
number of shares] shares of common stock, $0.01 par value per share, of the Company (“Common
Stock”) (the “Shares”) at $[insert price per share] per Share. Unless earlier terminated, this
option shall expire on [ten years from date of grant] (the “Final Exercise Date”).

It is intended that the option evidenced by this agreement shall not be an incentive stock option
as defined in Section 422 of the Internal Revenue Code of 1986, as amended and any regulations
promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term
“Participant”, as used in this option, shall be deemed to include any person who acquires the right
to exercise this option validly under its terms.

2. Vesting Schedule.

This option will become exercisable (“vest”) as to 33.33% of the original number of Shares on the
first, second, and third anniversary of the Grant Date. This option shall expire upon, and will not
be exercisable after, the Final Exercise Date.

The right of exercise shall be cumulative so that to the extent the option is not exercised in any
period to the maximum extent permissible it shall continue to be exercisable, in whole or in part,
with respect to all shares for which it is vested until the earlier of the Final Exercise Date or
the termination of this option under Section 3 hereof or the Plan.

3. Exercise of Option.

     (a) Form of Exercise. Each election to exercise this option shall be in writing,
signed by the Participant, and received by the Company at its principal office, accompanied by this
agreement, and payment in full in the manner provided in the Plan. The Participant may purchase
less than the number of shares covered hereby, provided that no partial exercise of this option may
be for any fractional share or for fewer than ten whole shares.

     (b) Continuous Relationship with the Company Required. Except as otherwise provided
in this Section 3, this option may not be exercised unless the Participant, at the time he or she
exercises this option, is, and has been at all times since the date of grant of this option, a
director of the Company or any parent or subsidiary of the Company as defined in Section 424(e) or
(f) of the Code (an “Eligible Participant”).

     (c) Termination of Relationship with the Company. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraph (d) below, the right to
exercise this option shall terminate 60 days after such cessation (but in no event after the Final
Exercise Date), provided that this option shall be exercisable only to the extent
that the Participant was entitled to exercise

 

 

this option on the date of such cessation.

     (d) Exercise Period Upon Death or Disability. If the Participant dies or becomes
disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date
while he or she is an Eligible Participant and the Company has not terminated such relationship for
“cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of
180 days following the date of death or disability of the Participant, by the Participant,
provided that this option shall be exercisable only to the extent that this option
was exercisable by the Participant on the date of his or her death or disability, and further
provided that this option shall not be exercisable after the Final Exercise Date.

4. Withholding.

No Shares will be issued pursuant to the exercise of this option unless and until the Participant
pays to the Company, or makes provision satisfactory to the Company for payment of, any federal,
state or local withholding taxes required by law to be withheld in respect of this option.

5. Nontransferability of Option.

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the
Participant, either voluntarily or by operation of law, except by will or the laws of descent and
distribution, and, during the lifetime of the Participant, this option shall be exercisable only by
the Participant.

6. Provisions of the Plan.

This option is subject to the provisions of the Plan, a copy of which is furnished to the
Participant with this option.

     IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal
by its duly authorized officer. This option shall take effect as a sealed instrument.

	 	 	 	 	 
	 	Aspect Medical Systems, Inc.

 	 
	Dated: _________ 	By:  	 	 
	 	Michael Falvey 	 
	 	Secretary/Treasurer of the Corporation 	 

 

 

	 	 	 	 	 

PARTICIPANT’S ACCEPTANCE

     The undersigned hereby accepts the foregoing option and agrees to the terms and conditions
thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s Amended and
Restated 1998 Director Equity Incentive Plan.

	 	 	 	 	 	 
	 	 	PARTICIPANT:
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	

	 	Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]